More importantly, the reperfusion or restoration of blood flow after ischemia can also induce the increase of ROS and lipid peroxidation, leading to tissue neuronal damage and worsening of the inflammatory response
Options may include switching to a different GLP-1 medication, adjusting the dose, or developing a plan to support weight maintenance through nutrition and behavioral strategies during the gap
This long-term commitment can be a factor in deciding which form is preferable
10.1089/ars.2011.4255 Antioxid
There additionally exists a safety argument for using MRAs in combination with SGLT2 inhibitors to reduce the risk of hyperkalemia, since the latter medication class has a modest potassium lowering effect as suggested by a recent post hoc analysis of MRA use in DAPA-HF [106]
Glucagon is emerging as a hormone with dual facets in metabolic diseases, characterized by its contrasting physiological responses of inducing hyperglycemia and promoting weight loss through increased energy metabolism [104]